Eurofins Scientific SE (XTER:ESF0) Current Accrued Expense: € Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTER:ESF0 Eurofins Scientific SE XTER:ESF0
79 GF Score
Price €78.36
GF Value €66.50
Valuation Modestly Overvalued
! 7 Warning Signs
View Full Analysis

What is Eurofins Scientific SE Current Accrued Expense?

Eurofins Scientific SE XTER:ESF0 +0.21% 79 Current Accrued Expense is € Mil as of Jun. 2026. GuruFocus rates XTER:ESF0 with a GF Score™ of 79/100 and a GF Value™ of €66.50 (Modestly Overvalued). The stock has 7 warning signs investors should review.

Eurofins Scientific SE's Current Accrued Expense for the quarter that ended in Jun. 2026 was € Mil.

Eurofins Scientific SE Current Accrued Expense Related Terms

Eurofins Scientific SE Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for Eurofins Scientific SE's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eurofins Scientific SE Current Accrued Expense Chart

Eurofins Scientific SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Accrued Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Eurofins Scientific SE Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -
XTER:ESF0
79GF Score
Eurofins Scientific SE XTER:ESF0
Current Accrued Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eurofins Scientific SE Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of € Mil mean?
Eurofins Scientific SE (XTER:ESF0) has a Current Accrued Expense of € Mil as of Jun. 2026. Current Accrued Expense records the total amount of accrued expenses. View historical data on Eurofins Scientific SE and its competitors.
Is Eurofins Scientific SE's Current Accrued Expense too high?
Eurofins Scientific SE's current Current Accrued Expense is € Mil. Overall, Eurofins Scientific SE has a GF Score™ of 79/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Eurofins Scientific SE's Current Accrued Expense compare to TMO and DHR?
Eurofins Scientific SE's Current Accrued Expense of € Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Medical Diagnostics & Research company?
A good Current Accrued Expense depends on the Medical Diagnostics & Research industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on Eurofins Scientific SE and its competitors. Eurofins Scientific SE's current Current Accrued Expense is € Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eurofins Scientific SE stock overvalued right now?
Based on GuruFocus' analysis, Eurofins Scientific SE (XTER:ESF0) is currently considered Modestly Overvalued. The stock's GF Value™ is €66.50, compared to a current price of €78.36 — trading 17.8% above its estimated fair value. The current Current Accrued Expense is € Mil. Eurofins Scientific SE's overall GF Score™ is 79/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For Eurofins Scientific SE (XTER:ESF0), the current Current Accrued Expense is € Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eurofins Scientific SE (XTER:ESF0) Overvalued in 2026?

Based on GuruFocus' analysis, Eurofins Scientific SE stock appears to be overvalued. The current stock price of €78.36 is trading 17.8% above its estimated GF Value™ of €66.50. GuruFocus considers Eurofins Scientific SE to be Modestly Overvalued.

Key valuation signals for XTER:ESF0:

  • Current Accrued Expense: € Mil
  • GF Value™: €66.50 vs. price of €78.36 (17.8% above fair value)
  • GF Score™: 79/100 with 7 warning signs

No single metric tells the full story. See the XTER:ESF0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Eurofins Scientific SE Business Description

Address 23 Val Fleuri, Luxembourg, LUX, 1526
Eurofins Scientific SE is a Luxembourg-based laboratory testing company operating a decentralized network of laboratories and service companies worldwide. It provides analytical testing and laboratory services across several segments: food, feed, and environmental testing; biopharmaceutical services, including contract research and bioanalytical testing; diagnostic services and products for clinical and medical applications; and consumer product and technology testing. Its tests assess the safety, identity, composition, authenticity, purity, origin, and traceability of biological substances and products. Customers include food producers, pharmaceutical and biotechnology companies, healthcare providers, government agencies, and consumer goods manufacturers. Eurofins operates a large network of laboratories and sites across Europe, North America, and the rest of the world, with Europe and North America representing the largest revenue regions. Revenue is generated primarily through fee-for-service testing contracts, diagnostic testing, and related laboratory services.
79GF Score

Get the complete analysis for XTER:ESF0

Current Accrued Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€78.36
Price
€66.50
GF Value